Pregled bibliografske jedinice broj: 1188283
Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience
Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience // Diagnostics, 12 (2022), 4; 866-880 doi:10.3390/diagnostics12040866 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1188283 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Long-Term Outcome of Differentiated Thyroid Cancer
Patients-Fifty Years of Croatian Thyroid Disease
Referral Centre
Experience
(Long-Term Outcome of Differentiated Thyroid Cancer
Patients-Fifty Years of Croatian Thyroid
Disease Referral Centre Experience)
Autori
Jukić, Tomislav ; Blažeković, Ivan ; Franceschi, Maja ; Petranović Ovčariček, Petra ; Bosak Butković, Marija ; Dabelić, Nina ; Granić, Roko ; Punda, Marija ; Sonicki, Zdenko ; Vagić, Davor ; Fröbe, Ana ; Kusić, Zvonko
Izvornik
Diagnostics (2075-4418) 12
(2022), 4;
866-880
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
differentiated thyroid cancer ; papillary ; follicular ; survival rates ; prognostic features ; recurrence ; follow-up
Sažetak
Background: Indolent nature but a high incidence of differentiated thyroid cancer (DTC) remains a challenge for optimizing patient care. Therefore, prognostic factors present valuable information for determining an adequate clinical approach. Methods: This study assessed prognostic features of 1167 papillary (PTC) and 215 follicular (FTC) thyroid cancer patients that had undergone surgery between 1962 and 2012, and were followed-up up to 50 years in a single institution, till April 2020. Age, gender, tumor size, presence of local and distant metastases at presentation, extrathyroidal extension, disease recurrence, and cancer-specific survival were evaluated. Results: In multivariate analysis, factors affecting the worse outcome were age (p = 0.005), tumor size (p = 0.006), and distant metastases (p = 0.001) in PTC, while extrathyroidal extension (p < 0.001), neck recurrence (p = 0.002), and distant metastases (p < 0.001) in FTC patients. Loco-regional recurrence rate was 6% for PTC and 4.7% for FTC patients, while distant metastases were detected in 4.2% PTC and 14.4% of FTC patients. The 10-year cancer- specific survival rates for PTC and FTC were 98.6% and 89.8%, respectively (p < 0.001). Conclusions: Negative prognostic factors, besides distant metastases, were older age and greater tumor size in PTC, and extrathyroidal extension and neck recurrence in FTC patients. The recurrence and mortality rates were very low.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Stomatološki fakultet, Zagreb,
Hrvatska akademija znanosti i umjetnosti,
Medicinski fakultet, Zagreb,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar",
KBC "Sestre Milosrdnice",
Medicinski fakultet, Osijek
Profili:
Ana Fröbe
(autor)
Davor Vagić
(autor)
Ivan Blažeković
(autor)
Nina Dabelić
(autor)
Marija Punda
(autor)
Petra Petranović Ovčariček
(autor)
Tomislav Jukić
(autor)
Roko Granić
(autor)
Maja Franceschi
(autor)
Zvonko Kusić
(autor)
Zdenko Sonicki
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus